ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 6645

$2.61M Total Retail Price of All Prescriptions

Rank: 49 out of 6645

769 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 769 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 28,797 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$89 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,265 1,221 1 2
SIMVASTATIN 1,068 1,041 2 1
ALENDRONATE SODIUM 1,010 993 3 14
OMEPRAZOLE 915 899 4 6
CREON 886 869 10 5 114
DIOVAN HCT 842 828 6 64
METFORMIN HCL 700 668 7 7
LIDODERM 699 694 8 53
LEVOTHYROXINE SODIUM 680 674 9 4
TAMSULOSIN HCL 640 640 10 22
CLOPIDOGREL 636 631 11 36
PLAVIX 575 571 12 49
CELEBREX 528 526 13 54
NEXIUM 515 513 14 40
METOPROLOL SUCCINATE 503 498 15 24
DONEPEZIL HCL 483 474 16 27
GLYBURIDE-METFORMIN HCL 470 457 R 17 95
ATENOLOL 470 464 17 8
LOSARTAN-HYDROCHLOROTHIAZIDE 456 437 19 62
NIFEDIPINE ER 429 421 20 82
MELOXICAM 428 417 21 46
AVODART 411 411 22 99
DIOVAN 397 397 23 19
ATORVASTATIN CALCIUM 325 312 24 10
EVISTA 325 311 24 90
DEXILANT 310 305 26 102
AZITHROMYCIN 301 293 27 44
FENOFIBRATE 300 295 28 74
ZOLPIDEM TARTRATE 299 298 29 17
MECLIZINE HCL 287 287 30 122
TRIAMCINOLONE ACETONIDE 282 276 31 55
METOCLOPRAMIDE HCL 277 276 32 120
CRESTOR 254 237 33 34
LOVAZA 251 251 34 68
JANUVIA 250 250 35 38
LOSARTAN POTASSIUM 242 234 36 12
JALYN 227 226 37 354
GABAPENTIN 226 226 38 18
LISINOPRIL 218 210 39 3
LIPITOR 216 215 40 69
HYDROCODONE-ACETAMINOPHEN 208 204 S3 41 5
ISOSORBIDE MONONITRATE ER 207 207 42 66
BENAZEPRIL HCL 204 193 43 21
MEGESTROL ACETATE 200 199 R 44 104
ACTONEL 198 198 45 92
NAMENDA 190 187 46 41
ALLOPURINOL 188 188 47 31
BACLOFEN 184 184 48 100
PEN NEEDLE 179 164 49 159
BENICAR HCT 175 165 50 158
CARVEDILOL 163 147 51 25
RANITIDINE HCL 159 146 52 51
SERTRALINE HCL 158 158 53 43
FUROSEMIDE 158 158 53 11
LEVOFLOXACIN 155 151 55 83
SINGULAIR 151 151 56 76
FORTEO 145 135 57 280
ACTOS 129 129 58 71
NITROSTAT 128 128 59 193
METOPROLOL TARTRATE 125 120 60 13
HYDROCHLOROTHIAZIDE 124 118 61 9
GLIPIZIDE 122 118 62 23
CLOTRIMAZOLE-BETAMETHASONE 121 121 63 177
BENICAR 113 113 64 84
GLIMEPIRIDE 111 111 65 47
OXYBUTYNIN CHLORIDE ER 109 109 66 179
CILOSTAZOL 108 108 67 202
ACIPHEX 101 101 68 167
DICYCLOMINE HCL 101 101 68 278
AMOXICILLIN 100 93 70 107
ADVAIR DISKUS 96 96 71 45
PANTOPRAZOLE SODIUM 93 93 72 29
WARFARIN SODIUM 91 91 73 16
ZENPEP 89 89 74 210
NIFEDICAL XL 85 85 75 295
ENALAPRIL MALEATE 84 84 76 75
DIGOXIN 83 83 77 59
ZOSTAVAX 82 77 78 115
DOXAZOSIN MESYLATE 82 82 78 81
BONIVA 79 79 80 191
ALCOHOL SWABS 79 70 80 319
MONTELUKAST SODIUM 78 78 82 128
IBUPROFEN 76 71 83 42
KETOCONAZOLE 74 74 84 196
KLOR-CON 8 70 70 85 123
TRIAMTERENE-HCTZ 70 69 85 52
GLYBURIDE 68 68 R 87 58
PREDNISONE 67 55 88 57
HYDROXYZINE HCL 65 65 R 89 161
INSULIN SYRINGE 64 64 90 61
PREMPRO 63 61 R 91 369
PROAIR HFA 61 61 92 32
NATEGLINIDE 59 59 93 220
IBANDRONATE SODIUM 59 57 93 147
DEXTROSE IN LACTATED RINGERS 58 58 10 95 706
ANTARA 58 58 95 361
AMIODARONE HCL 57 57 97 160
VESICARE 57 57 97 148
NEOMYCIN-POLYMYXIN-DEXAMETH 56 54 99 390
CIPROFLOXACIN HCL 54 49 100 67
BENAZEPRIL-HYDROCHLOROTHIAZIDE 53 43 101 181
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 102 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.